Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Rosuvastatin on Adenosine Metabolism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age 18 - 50 years~* Signed informed consent~Exclusion Criteria:~* hypertension~* hypercholesterolemia~* diabetes Mellitus~* alanine aminotransferase \> 90 U/L~* creatinine Kinase \> 440 U/L~* cardiovascular disease~* GFR \< 80 ml/min

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): None
- 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).